8-K Spyre Therapeutics, Inc. 2026-09-08
no anchors
| Fact | Value | Period | Source |
|---|---|---|---|
| filed_by | {"cik": "0001636282", "company": "Spyre Therapeutics, Inc.", "accession": "0001636282-26-0 | 2026-09-08 | sec_8k |
| filing_filed_at | {"value": "2026-09-08T08:01:57", "timezone": "US/Eastern (EDGAR acceptance, as filed)"} | 2026-09-08 | sec_8k |
| filing_form_type | {"value": "8-K"} | 2026-09-08 | sec_8k |
| filing_items | {"items": {"7.01": "Regulation FD Disclosure", "8.01": "Other Events", "9.01": "Financial | 2026-09-08 | sec_8k |
Cite as: FACTANKER, https://factanker.com/entity/3c328e2a-76e2-4814-b2fc-77d45a0642cc